Global X HealthTech ETF (HEAL) Valuation
HEAL valuation today
Holdings combined · company data as of Oct 26, 2026- P/E (TTM)
- 88.8 trailing earnings
- Forward P/E
- 27.7 analyst estimates
- Price / sales
- 2.22
- Price / book
- 4.60
- EV / EBITDA
- 21.8
- Earnings yield
- 1.13% inverse of P/E
- Dividend yield
- 0.07% of the holdings
- Return on equity
- 5.2% combined
- Net margin
- 2.5% combined
- Beta
- 1.45 weighted, vs S&P 500
HEAL valuation vs other stock ETFs
| ETF | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE | Net margin | Loss-makers |
|---|---|---|---|---|---|---|---|---|
| HEAL | 88.8 | 27.7 | 2.22 | 4.60 | 0.07% | 5.2% | 2.5% | 27.5% |
| SPY | 25.9 | 19.9 | 3.67 | 5.47 | 1.08% | 21.1% | 14.2% | 1.9% |
| QQQ | 34.2 | 23.4 | 5.93 | 9.27 | 0.58% | 27.1% | 17.4% | 6.9% |
| DIA | 20.9 | 18.4 | 3.16 | 5.52 | 1.55% | 26.4% | 15.1% | 0.0% |
| VTI | 28.2 | 19.4 | 3.31 | 5.00 | 1.07% | 17.7% | 11.8% | 4.6% |
| IWM | n/m | 13.9 | 1.25 | 2.03 | 1.38% | −1.7% | −1.0% | 28.1% |
Same method for every fund. n/m = not meaningful (combined trailing earnings below zero or close to it). Loss-makers = weight of holdings with negative trailing earnings.
HEAL valuation by sector
| Sector | Weight | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE |
|---|---|---|---|---|---|---|---|
| Healthcare | 95.8% | 88.8 | 27.7 | 2.22 | 4.60 | 0.07% | 5.2% |
HEAL earnings yield vs bond yields
Earnings yield = earnings ÷ price (1 ÷ P/E). The gap to bond yields is a rough gauge of the extra return stocks are priced to deliver.
How HEAL weight splits by P/E
Share of the covered weight in companies with a trailing P/E in each range.
HEAL largest holdings: valuation
| Symbol | Company | Weight | P/E | Fwd P/E | P/S | Div. yield | Share of earnings |
|---|---|---|---|---|---|---|---|
| VEEV | Veeva Systems Inc. | 6.74% | 50.9 | 30.2 | 14.5 | — | 14.08% |
| IQV | IQVIA Holdings Inc. | 6.13% | 33.2 | 18.4 | 2.6 | — | 19.64% |
| OSCR | Oscar Health, Inc. | 5.92% | 24.7 | 588.2 | 0.6 | — | 25.45% |
| PME | Pro Medicus Ltd | 4.83% | — | — | — | — | — |
| RMD | ResMed Inc. | 4.29% | 22.9 | 18.5 | 5.9 | 1.10% | 19.88% |
| DXCM | DexCom, Inc. | 4.26% | 34.1 | 28.2 | 6.5 | — | 13.26% |
| GEHC | GE HealthCare Technologies Inc. | 3.91% | 16.0 | 12.1 | 1.5 | 0.23% | 25.99% |
| TEM | Tempus AI, Inc. | 3.89% | — | — | 8.2 | — | −8.93% |
| WAY | Waystar Holding Corp. | 3.74% | 39.1 | 12.8 | 4.4 | — | 10.16% |
| HIMS | Hims & Hers Health, Inc. | 3.67% | — | 73.5 | 2.5 | — | −8.56% |
| PHIA | Koninklijke Philips NV | 3.65% | — | — | — | — | — |
| WDH | Demant A/S | 3.48% | — | — | — | — | — |
| DOCS | Doximity, Inc. | 3.42% | 36.4 | 19.8 | 8.4 | — | 9.98% |
| ISRG | Intuitive Surgical, Inc. | 3.30% | 48.9 | 33.3 | 13.7 | — | 7.17% |
| IRTC | iRhythm Technologies, Inc. | 3.19% | — | 90.9 | 4.3 | — | −1.31% |
| HTFL | Heartflow, Inc. | 3.02% | — | — | 19.8 | — | −1.60% |
| HNGE | Hinge Health, Inc. | 3.01% | 32.7 | 33.0 | 11.1 | — | 9.78% |
| PODD | Insulet Corporation | 2.87% | 26.4 | 54.9 | 3.2 | — | 11.54% |
| TMDX | TransMedics Group, Inc. | 2.26% | 18.3 | 37.3 | 3.7 | — | 13.12% |
| PRVA | Privia Health Group, Inc. | 2.03% | 107.2 | 17.3 | 1.2 | — | 2.01% |
| NRIX | Nurix Therapeutics, Inc. | 1.96% | 10.0 | — | 3.8 | — | 20.67% |
| 0241 | Alibaba Health Information Technology Ltd | 1.88% | — | — | — | — | — |
| LFST | LifeStance Health Group, Inc. | 1.74% | 90.3 | 52.6 | 2.8 | — | 2.04% |
| INSP | Inspire Medical Systems, Inc. | 1.55% | 15.2 | 59.2 | 2.2 | — | 10.88% |
| RXRX | Recursion Pharmaceuticals, Inc. | 1.42% | — | — | 33.9 | — | −47.42% |
Share of earnings = the holding's part of the fund's combined trailing profit. Green: earns more than its weight; orange: less. Symbol links go to each company's key metrics.
About HEAL valuation
Adding up its 32 holdings with company data, HEAL trades at 88.8 times trailing earnings and 27.7 times analysts' forward estimates, with a price-to-book ratio of 4.60 and a dividend yield of 0.07%. Its earnings yield of 1.13% is 4.20 percentage points below the 5.33% yield to maturity of the U.S. bond market (AGG).
The ten largest holdings are 47.4% of the fund and earn 121.0% of its combined profit. Companies that lost money over the past year are 27.5% of the covered weight.
How these figures are calculated. Each ratio treats the fund as one company: the earnings, sales and book value of every holding are added up in proportion to its weight and divided into the fund's price. In practice that is a weighted harmonic mean, so a single stock with a very high P/E cannot distort the result, and loss-making companies reduce the fund's earnings instead of being dropped. Covers 84.2% of the fund's weight (U.S.-listed stocks with company data); company figures as of October 26, 2026.
Related: HEAL chart, HEAL performance, HEAL holdings, HEAL dividends.
HEAL valuation FAQ
What is the P/E ratio of HEAL?
Based on its holdings, HEAL has a trailing P/E of 88.8 and a forward P/E of 27.7 (earnings of all covered holdings combined in proportion to their weights, as of October 26, 2026).
What is the earnings yield of HEAL?
The trailing earnings yield is 1.13% (1 ÷ P/E) and the forward earnings yield 3.61%. For comparison the U.S. bond market (AGG) yields 5.33% to maturity and T-bills about 3.91%.
Is HEAL more expensive than the S&P 500?
HEAL trades at 88.8 times trailing earnings versus 25.9 for the S&P 500 (SPY); on forward estimates the figures are 27.7 and 19.9.
What is the price-to-book ratio of HEAL?
The holdings of HEAL trade at 4.60 times book value, with a combined return on equity of 5.2%.